{
    "clinical_study": {
        "@rank": "82144", 
        "arm_group": [
            {
                "arm_group_label": "Lactobacilli", 
                "arm_group_type": "Active Comparator", 
                "description": "30 Participants with verum"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "30 Participants"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is the improvement of the penile linked neovaginal flora in\n      male-to-female transsexuals after application of oral probiotics."
        }, 
        "brief_title": "Oral Administration of Four Lactobacillus Species Preparation to Improve the Quality of the Neovaginal Flora in Male to Female Transsexual Patients", 
        "condition": "Reduction or Absence of Lactobacilli in Neovaginal Flora", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Participants underwent the sex reassignment surgery (SRS) with the technique of the\n        inverted penile skin flap longer than 1 year.\n\n        All transsexual women treated according to the Standards of Care of the World Professional\n        Association of Transgender Health (WPATH).\n\n        Exclusion Criteria:\n\n          -  clinical signs of vaginal or urinary tract infection,\n\n          -  abnormal neovaginal discharge,\n\n          -  neoplasia,\n\n          -  bleeding,\n\n          -  diarrhoea,\n\n          -  constipation,\n\n          -  rectal pathologies including hemorrhoids,\n\n          -  antibiotic therapy in the previous 4 weeks"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708148", 
            "org_study_id": "MUW EK982/2010"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lactobacilli", 
                "description": "lyophilised L. rhamnosus, L. jensenii, L. crispatus, L. gasseri and sodium alginate", 
                "intervention_name": "Probiotics", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "control group would receive a oral lactose placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria", 
                    "zip": "1090"
                }, 
                "name": "Department of Obstetrics and Gyecology, AKH"
            }
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "Nugent Score", 
            "safety_issue": "No", 
            "time_frame": "day 0 day 7 of oral probiotic application"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Austria: Agency for Health and Food Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Using Nugent scoring system, from each participant first swab from neovagina and rectum will be taken before start of oral probiotic use.(baseline information) Second swab from neovagina and rectum will be taken on the day following the last administration.(information about change in Nugent)", 
            "measure": "change in Nugent score between baseline and end of treatment (improvement or no improvement).", 
            "safety_issue": "No", 
            "time_frame": "day 0 day 7 of oral probiotic application"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708148"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Assistant Prof. Ljubomir Petricevic MD", 
            "investigator_title": "Ass. Prof MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "From each participant, the swab from neovagina and rectum for microbiologic cultures will be taken on the day following the last administration. Isolation of oral applied probiotic strains.", 
            "measure": "Isolation of specific Lactobacilli from neovaginal microbiologic cultures after oral administration of probiotic", 
            "safety_issue": "No", 
            "time_frame": "Day 7 of oral probiotic application"
        }, 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Natural Resources and Life Sciences, Vienna, Austria", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}